Connect on WhatsApp
The current prices are delayed, login to your account for live prices
XXX
0.00 0.00 (0.00%)
facebook sharing button facebook twitter sharing button Twitter whatsapp sharing button Whatsapp copy
Buy Sell
Expand

Performance

Today’s Low

736.15

Today’s High

796.15

Open Price

745.00

Prev. Close

745.55

Volume

79,04,749

Futures and Options

Expiry
Pricecall
Strike price
put Price
EXPIRYPRICE
24 Sep
+Buy Sell
55.00-5.004.000.001

About

Cipla is a global pharmaceutical leader with a legacy of over eight decades, driven by its purpose of Caring for Life. The company has built a strong global footprint, serving patients in over 80 countries with a portfolio of 1,500+ products across multiple therapeutic areas and 50+ dosage forms. Cipla is committed to making healthcare accessible and affordable, with a strategic presence in key markets such as India, South Africa, the U.S., and other emerging economies. Its pioneering role in offering affordable HIV/AIDS treatment in Africa is a testament to its patient-centric approach and social responsibility. Recognized for its innovation, sustainability, and strong governance, Cipla remains a trusted partner for global health stakeholders and continues to deliver long-term value to its shareholders.

FAQ’s ON Axis Bank

Cipla Limited is a publicly traded company listed on the Bombay Stock Exchange (BSE) and the National Stock Exchange (NSE) of India. As of December 31, 2022, the promoter group, led by Yusuf K. Hamied and his family, held approximately 33.61% of the company's equity shares. The remaining shares are held by institutional investors, mutual funds, and individual shareholders.

Yes, Cipla is considered a reputable company in the pharmaceutical industry. In Q3 FY25, Cipla reported a 49% increase in net profit, driven by strong domestic demand for respiratory and urology treatments, despite a slight decline in U.S. sales. The company has a longstanding commitment to providing affordable medicines globally and has been recognized for its contributions to public health.

Yes, Cipla is a multinational pharmaceutical company headquartered in Mumbai, India. It operates in over 80 countries and has 34 manufacturing units across India. Cipla's global presence includes subsidiaries such as Invagen Pharmaceuticals in the U.S. and Cipla Medpro in South Africa.

As of recent industry reports, Cipla is ranked among the top 5 pharmaceutical companies in India by market capitalization and domestic sales. It consistently competes with other major players like Sun Pharma, Dr. Reddy’s, and Lupin in terms of prescription volumes and revenue.

The full form of CIPLA is Chemical, Industrial & Pharmaceutical Laboratories. It was founded in 1935 by Dr. Khwaja Abdul Hamied in Mumbai, India.

You can buy Axis Bank shares using Navia App. Open a Free Demat account and add the scrip in the watchlist. Select buy and enter the bid quantity to buy the stock.

The share price of any stocks is volatile and keeps changing throughout the day owing to different factors. Axis Bank Industries share price is “₹” as of “.”

XXX today high is and today low of is

Want to invest in this Stock?
Open a FREE Demat And Trading Account. Complete KYC in just 5 minutes.

Top ETFs

ADD PRICE ALERT

YOUR PERSONAL DETAILS

Note: Alert will be triggered to email ID